115 related articles for article (PubMed ID: 9191212)
1. Anti-myelin antibodies modulate experimental allergic encephalomyelitis in Biozzi ABH mice.
Morris MM; Piddlesden S; Groome N; Amor S
Biochem Soc Trans; 1997 May; 25(2):168S. PubMed ID: 9191212
[No Abstract] [Full Text] [Related]
2. Encephalitogenic epitopes of myelin basic protein, proteolipid protein, myelin oligodendrocyte glycoprotein for experimental allergic encephalomyelitis induction in Biozzi ABH (H-2Ag7) mice share an amino acid motif.
Amor S; O'Neill JK; Morris MM; Smith RM; Wraith DC; Groome N; Travers PJ; Baker D
J Immunol; 1996 Apr; 156(8):3000-8. PubMed ID: 8609422
[TBL] [Abstract][Full Text] [Related]
3. The myelin oligodendrocyte glycoprotein (MOG): a model for antibody-mediated demyelination in experimental autoimmune encephalomyelitis and multiple sclerosis.
Stefferl A; Brehm U; Linington C
J Neural Transm Suppl; 2000; (58):123-33. PubMed ID: 11128602
[TBL] [Abstract][Full Text] [Related]
4. Anti-myelin oligodendrocyte glycoprotein antibodies in multiple sclerosis.
Reder AT; Oger JJ
Neurology; 2004 Jun; 62(11):1922-3. PubMed ID: 15184588
[No Abstract] [Full Text] [Related]
5. Myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis in the common marmoset reflects the immunopathology of pattern II multiple sclerosis lesions.
Merkler D; Schmelting B; Czéh B; Fuchs E; Stadelmann C; Brück W
Mult Scler; 2006 Aug; 12(4):369-74. PubMed ID: 16900750
[TBL] [Abstract][Full Text] [Related]
6. Humoral immunity in multiple sclerosis and its animal model, experimental autoimmune encephalomyelitis.
Cross AH; Stark JL
Immunol Res; 2005; 32(1-3):85-97. PubMed ID: 16106061
[TBL] [Abstract][Full Text] [Related]
7. Pathogenic myelin oligodendrocyte glycoprotein antibodies recognize glycosylated epitopes and perturb oligodendrocyte physiology.
Marta CB; Oliver AR; Sweet RA; Pfeiffer SE; Ruddle NH
Proc Natl Acad Sci U S A; 2005 Sep; 102(39):13992-7. PubMed ID: 16172404
[TBL] [Abstract][Full Text] [Related]
8. Myelin-associated oligodendrocytic basic protein: identification of an encephalitogenic epitope and association with multiple sclerosis.
Holz A; Bielekova B; Martin R; Oldstone MB
J Immunol; 2000 Jan; 164(2):1103-9. PubMed ID: 10623862
[TBL] [Abstract][Full Text] [Related]
9. Polyreactive myelin oligodendrocyte glycoprotein antibodies: Implications for systemic autoimmunity in progressive experimental autoimmune encephalomyelitis.
Peterson LK; Tsunoda I; Masaki T; Fujinami RS
J Neuroimmunol; 2007 Feb; 183(1-2):69-80. PubMed ID: 17197039
[TBL] [Abstract][Full Text] [Related]
10. Role of B:T cell ratio in suppression of clinical signs: a model for silent MS.
Peterson LK; Tsunoda I; Libbey JE; Fujinami RS
Exp Mol Pathol; 2008 Aug; 85(1):28-39. PubMed ID: 18486939
[TBL] [Abstract][Full Text] [Related]
11. Cytokines and antibodies in myelin oligodendrocyte glycoprotein-induced experimental allergic encephalomyelitis.
Hjelmström P; Juedes AE; Ruddle NH
Res Immunol; 1998; 149(9):794-804; discussion 847-8, 855-60. PubMed ID: 9923635
[No Abstract] [Full Text] [Related]
12. Cross-reactivity between related sequences found in Acinetobacter sp., Pseudomonas aeruginosa, myelin basic protein and myelin oligodendrocyte glycoprotein in multiple sclerosis.
Hughes LE; Smith PA; Bonell S; Natt RS; Wilson C; Rashid T; Amor S; Thompson EJ; Croker J; Ebringer A
J Neuroimmunol; 2003 Nov; 144(1-2):105-15. PubMed ID: 14597104
[TBL] [Abstract][Full Text] [Related]
13. Cutting edge: C3, a key component of complement activation, is not required for the development of myelin oligodendrocyte glycoprotein peptide-induced experimental autoimmune encephalomyelitis in mice.
Calida DM; Constantinescu C; Purev E; Zhang GX; Ventura ES; Lavi E; Rostami A
J Immunol; 2001 Jan; 166(2):723-6. PubMed ID: 11145641
[TBL] [Abstract][Full Text] [Related]
14. C3d binding to the myelin oligodendrocyte glycoprotein results in an exacerbated experimental autoimmune encephalomyelitis.
Jégou JF; Chan P; Schouft MT; Griffiths MR; Neal JW; Gasque P; Vaudry H; Fontaine M
J Immunol; 2007 Mar; 178(5):3323-31. PubMed ID: 17312184
[TBL] [Abstract][Full Text] [Related]
15. The FcRgamma chain is not essential for induction of experimental allergic encephalomyelitis (EAE) or anti-myelin antibody-mediated exacerbation of EAE.
Breij EC; Heijnen P; Vloet R; Saito T; van de Winkel JG; Dijkstra CD; Amor S; Verbeek S
J Neuropathol Exp Neurol; 2005 Apr; 64(4):304-11. PubMed ID: 15835266
[TBL] [Abstract][Full Text] [Related]
16. Major histocompatibility complex haplotype RT1av1 is associated with relapsing/remitting experimental autoimmune encephalomyelitis.
Wallström E; Weissert R; Lorentzen J; Olsson T
Transplant Proc; 1997 May; 29(3):1686-9. PubMed ID: 9142233
[No Abstract] [Full Text] [Related]
17. The central nervous system-specific myelin oligodendrocytic basic protein (MOBP) is encephalitogenic and a potential target antigen in multiple sclerosis (MS).
Kaye JF; Kerlero de Rosbo N; Mendel I; Flechter S; Hoffman M; Yust I; Ben-Nun A
J Neuroimmunol; 2000 Jan; 102(2):189-98. PubMed ID: 10636488
[TBL] [Abstract][Full Text] [Related]
18. IL-6-deficient mice are resistant to the induction of experimental autoimmune encephalomyelitis provoked by myelin oligodendrocyte glycoprotein.
Okuda Y; Sakoda S; Bernard CC; Fujimura H; Saeki Y; Kishimoto T; Yanagihara T
Int Immunol; 1998 May; 10(5):703-8. PubMed ID: 9645618
[TBL] [Abstract][Full Text] [Related]
19. Improving biomarker identification with better designs and reporting.
Pepe MS; Feng Z
Clin Chem; 2011 Aug; 57(8):1093-5. PubMed ID: 21666069
[No Abstract] [Full Text] [Related]
20. The demyelinating potential of antibodies to myelin oligodendrocyte glycoprotein is related to their ability to fix complement.
Piddlesden SJ; Lassmann H; Zimprich F; Morgan BP; Linington C
Am J Pathol; 1993 Aug; 143(2):555-64. PubMed ID: 7688186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
